15:54 Feb 26

Akums Drugs & Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
482.25
+3.60 (+0.75%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Akums Drugs & Pharmaceuticals Ltd. Financials

Akums Drugs & Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
482.25
+3.60 (+0.75%)
15:54 Feb 26
Quality
image/svg+xml

86/100
High Financial Strength

Valuation
image/svg+xml

51/100
Affordable Valuation

Technical

52/100
Technically Neutral

Strength

5

Weakness

1

Opportunity

2

Threats

0

11.09 %

ROE %

8.22 %

ROA %

20.22

EPS

199.01

BVPS

8.21 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
3671.89 3654.82 4178.18 4118.16 4256.7
Operating Expenses +
3763.61 3316.86 4055.2 3653.67 3792.49
Raw Material
2432.8 2249.87 2537.9 2435.08 2493.2
Increase Decrease in Cost
-87.74 24.04 12.34 -1.65 -1.04
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
507.76 590.13 646.86 715.82 738.69
Miscellaneous Expenses
1699.21 896.4 1377.16 867.36 561.64
Operating Profit
-91.72 337.96 122.98 464.49 464.21
Other Income
22.63 46.1 34.02 52.12 110.96
Depreciation
94.68 112.81 125.64 153.45 154.43
Interest
16.66 46.25 50.61 34.6 74.72
Profit before tax and exceptio..
-180.42 225 -19.24 328.56 346.02
Exceptional Items
-12.98 -74.5 -26.03 16.7 -10.01
PBT
-193.4 150.5 -45.28 345.25 356.03
Provision for Taxation
57.68 52.48 -46.07 1.48 11.36
Net Profit
-251.08 98.02 0.79 343.78 324.66
NET Profit after MI
-252.54 94.86 -4.04 338.18 318.2
EPS
-17.65 6.63 -0.28 22.6 20.78
Operating Profit Margin (%)
-2.5 9.25 2.94 11.28 10.91
Net Profit Margin (%)
-6.88 2.6 -0.1 8.21 7.48

Akums Drugs & Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 75.30 75.30 75.30 75.30 75.30 75.30
FII 1.10 2.30 4.20 5.80 6.40 7.30
Public 14.50 9.30 8.90 7.40 7.00 7.60
Others 9.10 13.10 11.60 11.50 11.30 9.80
Shareholder Shares Holding %
Download Our App On: